Lazard Asset Management
XCUR icon

Lazard Asset Management’s Exicure XCUR Stock Holding History

Lazard Asset Management’s Portfolio XCUR Stock Details XCUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-296
Closed – – 2450
2024
Q1 		$0 Buy
+296
New +$924 ﹤0.01% 2410

Other funds holding XCUR

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lazard Asset Management's XCUR Position: Q2 2024 in Review

Lazard Asset Management sold out of Exicure (XCUR) in Q2 2024, closing a stake of 296 shares.

Lazard Asset Management first reported a position in XCUR in Q1 2024 and held it in 1 quarter. The position peaked at $0 in Q1 2024. 15 funds tracked by Wall St. Rank hold XCUR as of Q2 2024.

  • Lazard Asset Management reported no remaining Exicure position as of Q2 2024 after selling out during the quarter.
  • Lazard Asset Management sold 296 Exicure shares in Q2 2024.
  • Lazard Asset Management first reported a position in Exicure in Q1 2024 and held it in 1 quarter.
  • Lazard Asset Management's Exicure position peaked at $0 in Q1 2024.
  • 15 funds tracked by Wall St. Rank held Exicure as of Q2 2024.

Based on Lazard Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.